EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synergism in drug combination of new tuberculosis antibiotics for drug-resistant Mycobacterium tuberculosis in vitro

Run Huang iD, Yifan He iD, Jinghui Yang, Yidian Liu, Qin Sun iD, Ruoyan Ying iD, Wei Sha iD

Microbiology Spectrum · 04.08.2026 · 14 (8)

DOI: 10.1128/spectrum.02128-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 04.08.2026. Verfasst von Run Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tuberculosis, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Antitubercular Agents, Tuberculosis, Multidrug-Resistant. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The treatment of drug-resistant tuberculosis (DR-TB) faces significant challenges. Novel antituberculosis drugs such as bedaquiline (BDQ), pretomanid (Pa824), and delamanid (DLM) offer a promising treatment for DR-TB. However, the synergistic effects of these drugs have been insufficiently explored. In this research, we evaluated the synergistic effects of two dual-drug combinations (BDQ-Pa824 and BDQ-DLM) and four triple-drug combinations (BDQ-DLM-clofazimine [CFZ], BDQ-DLM-linezolid [LZD], BDQ-Pa824-CFZ, and BDQ-Pa824-LZD) against 30 Mycobacterium tuberculosis ( MTB ) strains isolated from TB patients. The results indicated that the synergistic antimycobacterial effects of BDQ-DLM-LZD and BDQ-Pa824-LZD show no statistically significant difference, suggesting that BDQ-DLM-LZD could be considered a potential therapeutic alternative for DR-TB. This provides evidence for the development of more flexible treatment options for DR-TB. IMPORTANCE The rapid emergence of antimicrobial resistance in Mycobacterium tuberculosis (MTB) presents a critical challenge for global public health. Given that the synergistic effects of antituberculosis drugs against drug-resistant tuberculosis have not been systematically analyzed. In this research, we evaluated the synergistic antimycobacterial efficacy of the new optimized antituberculosis regimen (BDQ-DLM-LZD or BDQ-DLM-CFZ) and the standard regimen (BDQ-Pa824-LZD or BDQ-Pa824-CFZ) for TB strains. This highlights the therapeutic substitutability of BDQ-DLM or BDQ-Pa824-based triple-drug regimens for TB strains.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisAntitubercular AgentsTuberculosis, Multidrug-ResistantDrug SynergismHumansMicrobial Sensitivity TestsDiarylquinolinesDrug Therapy, CombinationNitroimidazolesDrug Combinations

Stichwörter der Autor:innen

DR-TBFICIMICcombined drug sensitivitytuberculosis

Substanzen

Antitubercular AgentsbedaquilineDiarylquinolinesNitroimidazolesDrug Combinationspretomanid

Autor:innen und Institutionen

  • Department of Tuberculosis, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China.
  • Department of Clinical Laboratory, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China.
  • Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China.

ORCID-Profile: Run Huang, Yifan He, Qin Sun, Ruoyan Ying, Wei Sha

Förderung

  • National Key Research and Development Program of China

Zitieren

APA

Huang, R., He, Y., Yang, J., Liu, Y., Sun, Q., Ying, R., & Sha, W. (2026). Synergism in drug combination of new tuberculosis antibiotics for drug-resistant Mycobacterium tuberculosis in vitro. Microbiology Spectrum, 14(8). https://doi.org/10.1128/spectrum.02128-25

Vancouver

Huang R, He Y, Yang J, Liu Y, Sun Q, Ying R, et al. Synergism in drug combination of new tuberculosis antibiotics for drug-resistant Mycobacterium tuberculosis in vitro. Microbiology Spectrum. 2026;14(8). doi:10.1128/spectrum.02128-25

BibTeX
@article{Huang2026,
  author = {Huang, Run and He, Yifan and Yang, Jinghui and Liu, Yidian and Sun, Qin and Ying, Ruoyan and Sha, Wei},
  title = {Synergism in drug combination of new tuberculosis antibiotics for drug-resistant Mycobacterium tuberculosis in vitro},
  journal = {Microbiology Spectrum},
  year = {2026},
  volume = {14},
  number = {8},
  doi = {10.1128/spectrum.02128-25}
}
Kostenlos starten →